top of page
it's where dermatology lives
1/2
VIDEO: Upadacitinib efficacious, moderately safe long-term in adolescents with AD
Upadacitinib is efficacious and demonstrated a favorable benefit-risk profile for long-term treatment of AD in adolescents.
Jeremy Visser
Nov 27, 20241 min read
Combination dupilumab, abrocitinib effective in treating refractory pediatric AD
A combination of dupilumab and abrocitinib is effective in treating refractory AD in pediatric patients
Jeremy Visser
Nov 6, 20241 min read
Elimination diets have limited impact on pediatric AD
A new study being presented at the 2024 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Boston...
John Evans
Oct 25, 20241 min read
Link shown between AD, peripheral vascular disease
In a study published in Clinical and Experimental Dermatology , researchers from Yale School of Medicine identified a significant...
Allan Ryan
Oct 21, 20242 min read
VIDEO: Risk of pediatric AD associated with childhood obesity
Risk of pediatric AD is associated with childhood obesity and correlated to weight loss and gain.
Jeremy Visser
Sep 18, 20241 min read
VIDEO: Cendakimab safe, efficacious in treating moderate-to-severe AD
Cendakimab is safe and efficacious in treating moderate-to-severe AD in adult patients.
Jeremy Visser
Sep 4, 20241 min read
VIDEO: Impaired mobility in AD patients linked to sex and age
AD patients have an increased risk of impaired mobility if they are male or aged 40 to 59 years.
Jeremy Visser
Jul 24, 20241 min read
VIDEO: High sodium intake associated with increased risk of AD
High sodium intake is linked to an increased risk of AD and AD severity
Jeremy Visser
Jul 17, 20241 min read
Featured Posts
bottom of page